ALLO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Allogene Therapeutics Inc

NASDAQ | ALLO

1.46

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$319.12M

Market Cap

-

P/E Ratio

-0.98

EPS

$3.78

52 Week High

$0.86

52 Week Low

HEALTHCARE

Sector

ALLO Chart

Recent Chart
Price Action

ALLO Technicals

Tags:

ALLO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $22K
Total Revenue $22K
Cost Of Revenue $14M
Costof Goods And Services Sold $14M
Operating Income -$273M
Selling General And Administrative $65M
Research And Development $192M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense $181K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14M
Income Before Tax -$257M
Income Tax Expense $443K
Interest And Debt Expense -
Net Income From Continuing Operations -$258M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$243M
Net Income -$258M

Revenue & Profitability

Earnings Performance

ALLO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $549M
Total Current Assets $303M
Cash And Cash Equivalents At Carrying Value $75M
Cash And Short Term Investments $75M
Inventory -
Current Net Receivables $1.9M
Total Non Current Assets $245M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $81M
Short Term Investments $217M
Other Current Assets $9M
Other Non Current Assets -
Total Liabilities $127M
Total Current Liabilities $36M
Current Accounts Payable $5.4M
Deferred Revenue -
Current Debt -
Short Term Debt $7.5M
Total Non Current Liabilities $91M
Capital Lease Obligations $91M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $91M
Other Current Liabilities $23M
Other Non Current Liabilities $7.8M
Total Shareholder Equity $422M
Treasury Stock -
Retained Earnings -$1.8B
Common Stock $212K
Common Stock Shares Outstanding $195M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$200M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $14M
Capital Expenditures $694K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $76M
Cashflow From Financing $117M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $1.5M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$258M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $22K
Total Revenue $22K
Cost Of Revenue $14M
Costof Goods And Services Sold $14M
Operating Income -$273M
Selling General And Administrative $65M
Research And Development $192M
Operating Expenses $273M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense $181K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14M
Income Before Tax -$257M
Income Tax Expense $443K
Interest And Debt Expense -
Net Income From Continuing Operations -$258M
Comprehensive Income Net Of Tax -
Ebit -$257M
Ebitda -$243M
Net Income -$258M

ALLO News

ALLO Profile

Allogene Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Allogene Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company based in South San Francisco, California, specializing in the development of next-generation allogeneic T-cell therapies designed to target various forms of cancer. Leveraging its proprietary technology platform, Allogene aims to deliver transformative immuno-oncology treatments that enhance the body’s natural ability to fight cancer while minimizing associated treatment risks and complexities. With a strong pipeline of candidates and a dedicated focus on advancing therapeutic solutions, Allogene is positioned to significantly impact the oncology landscape.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
VINE
+10.76%
$0.39
KTTA
+32.06%
$1.39
BITF
+11.91%
$3.10
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
AMZE
+33.81%
$0.52
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
NVDA
-1.41%
$177.70
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
BIYA
+11.34%
$0.28
BYND
+2.00%
$1.04
TWOH
0.00%
$0.00
RUBI
-24.69%
$0.16
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
ITUB
+3.23%
$7.66
AFMD
-34.94%
$0.18
INTC
+5.13%
$38.70
CLSK
+13.34%
$15.24
SNAP
+0.23%
$7.62
ADTX
+27.38%
$4.00
INHD
-6.51%
$0.21
MSTR
+2.00%
$175.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KWM
+10.50%
$0.72
KSS
+7.49%
$24.10
RXRX
+0.91%
$4.41
ONMD
+55.63%
$2.21
KDLY
+7.20%
$0.49
ASST
+2.65%
$1.16
BMNU
+20.08%
$9.03
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
PLUG
+1.76%
$2.01
C
+1.31%
$102.50
CHR
0.00%
$0.04
IREN
+0.12%
$48.51
IBRX
+10.09%
$2.34
NEHC
+8.33%
$5.07
SMX
+209.42%
$53.84
KEY
+0.16%
$18.40
NIO
+0.72%
$5.49
DEFT
+20.86%
$1.68
ONDS
-3.80%
$7.92
WULF
+5.49%
$15.65
GOOG
-0.66%
$318.15
GOOGL
-0.33%
$318.88
ABVE
+15.58%
$3.04
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
TSLA
+0.65%
$429.38
CCCS
+0.96%
$7.32
PYPL
+0.99%
$61.83
FL
-0.37%
$24.01
APLD
+8.09%
$26.96
VALE
+0.75%
$12.60
CPRT
-0.79%
$38.75
FI
+0.06%
$60.80
AG
+8.35%
$14.63
RIVN
+4.70%
$16.94
VGFC
-1.90%
$0.05
VSA
-6.26%
$0.11
IVP
-9.92%
$0.12
CAN
+5.95%
$0.97
NLY
+1.02%
$22.67
WU
+0.58%
$8.67
CRCA
+19.42%
$4.39
CRCL
+7.47%
$78.07
DNN
+0.78%
$2.58
CDE
+5.03%
$17.00
ORCL
-1.44%
$201.99
SVMH
-14.58%
$0.73
AGL
+3.94%
$0.66
SPGC
-8.21%
$0.16
PSKY
+0.95%
$15.79
TMC
+11.40%
$6.49
SGHC
-6.74%
$10.93
TGI
+0.61%
$26.01
FNGB
+2.90%
$21.28
AMZN
+1.06%
$231.61
BURU
+5.26%
$0.23
MU
+1.62%
$234.01
FRO
-1.95%
$23.52
SOFI
+1.64%
$28.96
PLTR
+0.53%
$166.65
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
VINE
+10.76%
$0.39
KTTA
+32.06%
$1.39
BITF
+11.91%
$3.10
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
AMZE
+33.81%
$0.52
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
NVDA
-1.41%
$177.70
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
BIYA
+11.34%
$0.28
BYND
+2.00%
$1.04
TWOH
0.00%
$0.00
RUBI
-24.69%
$0.16
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
ITUB
+3.23%
$7.66
AFMD
-34.94%
$0.18
INTC
+5.13%
$38.70
CLSK
+13.34%
$15.24
SNAP
+0.23%
$7.62
ADTX
+27.38%
$4.00
INHD
-6.51%
$0.21
MSTR
+2.00%
$175.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KWM
+10.50%
$0.72
KSS
+7.49%
$24.10
RXRX
+0.91%
$4.41
ONMD
+55.63%
$2.21
KDLY
+7.20%
$0.49
ASST
+2.65%
$1.16
BMNU
+20.08%
$9.03
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
PLUG
+1.76%
$2.01
C
+1.31%
$102.50
CHR
0.00%
$0.04
IREN
+0.12%
$48.51
IBRX
+10.09%
$2.34
NEHC
+8.33%
$5.07
SMX
+209.42%
$53.84
KEY
+0.16%
$18.40
NIO
+0.72%
$5.49
DEFT
+20.86%
$1.68
ONDS
-3.80%
$7.92
WULF
+5.49%
$15.65
GOOG
-0.66%
$318.15
GOOGL
-0.33%
$318.88
ABVE
+15.58%
$3.04
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
TSLA
+0.65%
$429.38
CCCS
+0.96%
$7.32
PYPL
+0.99%
$61.83
FL
-0.37%
$24.01
APLD
+8.09%
$26.96
VALE
+0.75%
$12.60
CPRT
-0.79%
$38.75
FI
+0.06%
$60.80
AG
+8.35%
$14.63
RIVN
+4.70%
$16.94
VGFC
-1.90%
$0.05
VSA
-6.26%
$0.11
IVP
-9.92%
$0.12
CAN
+5.95%
$0.97
NLY
+1.02%
$22.67
WU
+0.58%
$8.67
CRCA
+19.42%
$4.39
CRCL
+7.47%
$78.07
DNN
+0.78%
$2.58
CDE
+5.03%
$17.00
ORCL
-1.44%
$201.99
SVMH
-14.58%
$0.73
AGL
+3.94%
$0.66
SPGC
-8.21%
$0.16
PSKY
+0.95%
$15.79
TMC
+11.40%
$6.49
SGHC
-6.74%
$10.93
TGI
+0.61%
$26.01
FNGB
+2.90%
$21.28
AMZN
+1.06%
$231.61
BURU
+5.26%
$0.23
MU
+1.62%
$234.01
FRO
-1.95%
$23.52
SOFI
+1.64%
$28.96
PLTR
+0.53%
$166.65
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.